Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: MWG Biotech To Sell Dharmacon s Synthetic RNA

NEW YORK, May 7-The research tool company MWG Biotech said last week that it will resell RNA synthesis products, services and technologies manufactured by Dharmacon Research, Inc.


The agreement covers markets worldwide, and is the first in an expected series of technical and marketing collaborations between the two companies.


This deal combines MWG Biotech's expertise in synthetic nucleic acid development and sale with Dharmacon's synthetic RNA products, allowing the two companies to expand their products and services, said MWG Biotech CEO Matthias Schonermark in a statement.


Dharmacon specializes in manufacturing synthetic RNA, used in structural studies and in RNA interference-based gene function research.


The Lafayette, Colo. company is privately owned.


MWG Biotech, based in Ebersberg, Germany, is a major manufacturer of synthetic DNA.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.